γδ T cells play dual roles in non-small cell lung cancer therapy
Lung cancer remains the deadliest malignancy in the world, and non-small cell lung cancer, which accounts for roughly 85 percent ...
Lung cancer remains the deadliest malignancy in the world, and non-small cell lung cancer, which accounts for roughly 85 percent ...
In an era where cancer immunotherapy is reshaping the oncology landscape, recent advancements spotlight an innovative approach that could revolutionize ...
In the relentless pursuit of more effective cancer therapies, researchers have turned their attention to an unlikely ally residing within ...
In a groundbreaking advancement that could redefine immunotherapy approaches in lung cancer, researchers have uncovered a sophisticated mechanism by which ...
New research from the Icahn School of Medicine at Mount Sinai, published on September 10, 2025, in the prestigious journal ...
Recent research has illuminated a substantial breakthrough in the treatment of non-small cell lung cancer (NSCLC) through the incorporation of ...
In a groundbreaking advancement for cancer research, City of Hope, one of America's premier cancer centers, has been awarded a ...
In the relentless battle against lung cancer, a formidable adversary that continues to claim more lives worldwide than any other ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine